Isturisa 1 mg film-coated tablets, Isturisa 5 mg film-coated tablets, Isturisa 10 mg film-coated tablets clinical trials

A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's disease

This study is looking at a medicine called Isturisa for children and teenagers with Cushing's disease. Researchers want to understand how the medicine works in the body, its effects, and if it's safe and well-tolerated for this age group.